Showing 1 - 8 results of 8 for search 'Elad Jacoby', query time: 3.32s Refine Results
  1. 1
    Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies

    Relapse and Resistance to CAR-T Cells and Blinatumomab in Hematologic Malignancies by Elad Jacoby

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

    Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia by Meir Rozenbaum, Meir Rozenbaum, Meir Rozenbaum, Amilia Meir, Yarden Aharony, Orit Itzhaki, Jacob Schachter, Ilan Bank, Elad Jacoby, Elad Jacoby, Elad Jacoby, Michal J. Besser, Michal J. Besser, Michal J. Besser

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Impact of cryopreservation on CAR T production and clinical response

    Impact of cryopreservation on CAR T production and clinical response by Karin Brezinger-Dayan, Orit Itzhaki, Jenny Melnichenko, Adva Kubi, Li-at Zeltzer, Elad Jacoby, Elad Jacoby, Abraham Avigdor, Ronnie Shapira Frommer, Michal J. Besser, Michal J. Besser, Michal J. Besser

    Published 2022-10-01
    Get full text
    Article
  4. 4
    The effect of prolonged physical activity performed during extreme caloric deprivation on cardiac function.

    The effect of prolonged physical activity performed during extreme caloric deprivation on cardiac function. by David Planer, David Leibowitz, Amir Hadid, Tomer Erlich, Nir Sharon, Ora Paltiel, Elad Jacoby, Chaim Lotan, Daniel S Moran

    Published 2012-01-01
    Get full text
    Article
  5. 5
    P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION

    P520: POINT OF CARE CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH ABERRANT CD19 ANTIGEN EXPRESSION by Ivetta Danylesko, Noga Shem-Tov, Ronit Yerushalmi, Elad Jacoby, Amos Toren, Orit Itzhaki, Roni Shouval, Avichai Shimoni, Avigdor Abraham, Arnon Nagler

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

    Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy by Ronnie Shapira-Frommer, Elad Jacoby, Orit Itzhaki, Abraham Nissani, Gal Markel, Jacob Schachter, Shaked Lev-Ari, Tomer Meirson, Nethanel Asher, Guy Ben-Betzalel, Michal J. Besser

    Published 2021-05-01
    Get full text
    Article
  7. 7
    Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies

    Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies by Katia Beider, Orit Itzhaki, Jacob Schachter, Ania Hava Grushchenko-Polaq, Valeria Voevoda-Dimenshtein, Evgenia Rosenberg, Olga Ostrovsky, Olivia Devillers, Ronnie Shapira Frommer, Li-at Zeltzer, Amos Toren, Elad Jacoby, Avichai Shimoni, Abraham Avigdor, Arnon Nagler, Michal J. Besser

    Published 2022-03-01
    Get full text
    Article
  8. 8
    CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity

    CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity by Elad Jacoby, Sang M. Nguyen, Thomas J. Fountaine, Kathryn Welp, Berkley Gryder, Haiying Qin, Yinmeng Yang, Christopher D. Chien, Alix E. Seif, Haiyan Lei, Young K. Song, Javed Khan, Daniel W. Lee, Crystal L. Mackall, Rebecca A. Gardner, Michael C. Jensen, Jack F. Shern, Terry J. Fry

    Published 2016-07-01
    Get full text
    Article

Search Tools: